Research emerging from two studies, published in same issue of Nature, has raised significant questions over just how safe CRISPR technology, after it was suggested that it may increase risk of cancer developing.
The research emerged from Cambridge University and the Karolinska Institute, as well as one paper produced by Novartis, with both groups suggesting that CRISPR-Cas9 gene editing may bring into action one key gene, p53.
Original Article: Research casts doubts over CRISPR safety